Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | 109.00%226.98K | -79.07%108.61K | 3.35%519K | 397.33%502.17K | 45.03%100.97K | 69.62K | -43.26%56.48K | |||
| Revenue from customers | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 33.33%8K |
| Other cash income from operating activities | 109.00%226.98K | -79.07%108.61K | 3.35%519K | 397.33%502.17K | 45.03%100.97K | --69.62K | ---- | ---- | ---- | -48.17%48.48K |
| Cash paid | 23.64%-1.78M | -0.60%-2.33M | -83.79%-2.32M | -151.91%-1.26M | 9.74%-501.09K | -29.32%-555.16K | -62.49%-429.28K | 41.80%-264.19K | 30.19%-453.9K | 13.70%-650.15K |
| Payments to suppliers for goods and services | 23.64%-1.78M | -0.60%-2.33M | -83.79%-2.32M | -151.91%-1.26M | 9.74%-501.09K | -29.32%-555.16K | -62.49%-429.28K | 41.80%-264.19K | 30.19%-453.9K | 13.70%-650.15K |
| Direct interest paid | ---- | ---- | ---- | 90.14%-5.95K | -0.46%-60.28K | ---60K | ---- | ---- | ---- | ---- |
| Direct interest received | -83.13%22.64K | 126.67%134.18K | 1,045.67%59.2K | 28.05%5.17K | 58.61%4.04K | -26.77%2.54K | -13.00%3.47K | 2.60%3.99K | 75.95%3.89K | -84.08%2.21K |
| Operating cash flow | 26.72%-1.53M | -20.05%-2.09M | -128.91%-1.74M | -66.73%-760.89K | 15.96%-456.36K | -27.52%-543K | -63.64%-425.8K | 42.18%-260.2K | 23.92%-450.01K | 7.57%-591.46K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 12.42%-6.63M | 72.09%-7.57M | -280.79%-27.11M | -18.60%-7.12M | -135.48%-6M | -901.99%-2.55M | -254.42K | -100.47%-3.02K | 135.20%644.47K | |
| Capital expenditure reported | 56.07%-7.52M | 7.13%-17.11M | -171.11%-18.42M | -13.20%-6.79M | -135.45%-6M | -846.81%-2.55M | ---269.25K | ---- | -102.93%-3.02K | 105.66%102.94K |
| Net PPE purchase and sale | -182.23%-463.46K | 93.94%-164.21K | -733.78%-2.71M | -43,319.89%-325.22K | ---749 | ---- | ---2.16K | ---- | ---- | 1,895.65%200K |
| Net business purchase and sale | ---- | ---- | ---150K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net investment purchase and sale | -100.05%-3.28K | 202.94%6M | ---5.83M | ---- | ---- | ---- | --16.99K | ---- | ---- | --541.54K |
| Net other investing changes | -63.41%1.36M | --3.7M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 12.42%-6.63M | 72.09%-7.57M | -280.79%-27.11M | -18.60%-7.12M | -135.48%-6M | -901.99%-2.55M | ---254.42K | ---- | -100.47%-3.02K | 135.20%644.47K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 210.53%16.9M | -83.00%5.44M | 313.77%32.01M | -10.45%7.74M | 197.08%8.64M | 197.46%2.91M | 119.56%977.74K | 34.93%445.31K | 148.52%330.03K | -90.99%132.8K |
| Net issuance payments of debt | ---- | ---- | ---- | ---- | ---- | ---- | --600K | ---- | ---- | ---- |
| Net common stock issuance | 208.78%16.95M | -82.87%5.49M | 312.52%32.06M | -2.70%7.77M | 174.65%7.99M | 669.95%2.91M | -15.17%377.74K | 34.93%445.31K | 148.52%330.03K | -90.99%132.8K |
| Net other financing activities | 41.97%-57.46K | -3.25%-99.03K | -36.34%-95.91K | -110.78%-70.35K | --652.5K | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 210.53%16.9M | -83.00%5.44M | 313.77%32.01M | -10.45%7.74M | 197.08%8.64M | 197.46%2.91M | 119.56%977.74K | 34.93%445.31K | 148.52%330.03K | -90.99%132.8K |
| Net cash flow | ||||||||||
| Beginning cash position | -74.43%1.45M | 126.40%5.66M | -5.41%2.5M | 469.95%2.65M | -28.38%464.1K | 84.89%647.97K | 111.96%350.45K | -42.66%165.34K | 181.24%288.33K | -90.67%102.52K |
| Current changes in cash | 307.28%8.74M | -233.31%-4.22M | 2,308.92%3.16M | -106.56%-143.17K | 1,286.20%2.18M | -161.80%-183.87K | 60.72%297.52K | 250.51%185.11K | -166.19%-122.99K | 118.64%185.81K |
| End cash Position | 603.24%10.19M | -74.43%1.45M | 126.40%5.66M | -5.41%2.5M | 469.95%2.65M | -28.38%464.1K | 84.89%647.97K | 111.96%350.45K | -42.66%165.34K | 181.24%288.33K |
| Free cash from | 49.58%-9.78M | 15.19%-19.4M | -190.26%-22.87M | -22.00%-7.88M | -108.89%-6.46M | -343.52%-3.09M | -167.95%-697.21K | 42.56%-260.2K | 23.41%-453.03K | 76.06%-591.46K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |